iBio Inc (FRA:0JV0)
€ 3.5145 0 (0%) Market Cap: 23.66 Mil Enterprise Value: 14.64 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 34/100

Q3 2022 Ibio Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: €430
Operator

Good day, and thank you for standing by. Welcome to the iBio fiscal 2022 third-quarter financial results conference call. (Operator instructions) I would now like to hand the conference over to Stephen Kilmer, Investor Relations. Please go ahead, sir.

Stephen Kilmer
iBio, Inc. - IR

Thank you. Good afternoon, everyone. Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements regarding our current expectations and projections about future events that are subject to risks and uncertainties. Reference to these risks and uncertainties are made in today's press release as disclosed in detail in the company's periodic and current filings with the US Securities and Exchange Commission.

No forward-looking statements can be guaranteed, and actual results may differ from the results discussed in the forward-looking statements. The information on this conference call is provided only as of today, and we undertake no obligation to update any forward-looking statements made on this call on account of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot